Overexpression of programmed death ligand 1 in dendritic cells inhibits allogeneic lymphocyte activation in mice

Journal of Surgical Research

Volumn 176, Issue 2, 2012, Pages

  Li, Wenzhi ^a   Wang, Xiang ^b   Chen, Renfu ^c   Zhu, Haitao ^c   Chen, Gang ^a   Sun, Xiaoqing ^c  

^a JINSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

dendritic cells; lymphocyte activation; mice; PD L1; tolerance

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; PROGRAMMED DEATH 1 LIGAND 1;

ANIMAL CELL; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; GENETIC TRANSFECTION; IN VITRO STUDY; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD274; CELL COMMUNICATION; DENDRITIC CELLS; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES; TRANSGENES; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 84863988980     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.12.009     Document Type: Article

References (42)

1. J. Tantravahi, K.L. Womer, and B. Kaplan Why hasn't eliminating acute rejection improved graft survival? Annu Rev Med 58 2007 369
2. R. Nurieva, S. Thomas, and C. Dong T-cell tolerance or function is determined by combinatorial co-stimulatory signals EMBO J 25 2006 262
3. R. Bahri, A. Naji, and A. Durrbach Dendritic cells secrete the immunosuppressive HLA-G molecule upon CTLA4-Ig treatment: Implication in human renal transplant acceptance J Immunol 183 2009 7054
4. C.R. Gilson, Z. Milas, and C.P. Larsen Anti-CD40 monoclonal antibody synergizes with CTLA4-Ig in promoting long term graft survival in murine models of transplantation J Immunol 183 2009 1625
5. A. Yamada, and M.H. Sayegh The CD154-CD40 co-stimulatory pathway in transplantation Transplantation 73 2002 36
6. H. Dong, G. Zhu, and L. Chen B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion Nat Med 5 1999 1365
7. B.M. Carreno, and M. Collins The B7 family of ligands and its receptors: New pathways for co-stimulation and inhibition of immune responses Annu Rev Immunol 20 2002 29
8. Y. Agata, A. Kawasaki, and T. Honjo Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes Int Immunol 8 1996 765
9. M.E. Keir, L.M. Francisco, and A.H. Sharpe PD-1 and its ligands in T-cell immunity Curr Opin Immunol 19 2007 309
10. A.H. Sharpe, E.J. Wherry, and R. Ahmed The function of programmed cell death1 and its ligands in regulating autoimmunity and infection Nat Immunol 8 2007 239
11. T. Yamazaki, H. Akiba, and H. Yagita Expression of programmed death 1 ligands by murine T cells and APC J Immunol 169 2002 5538
12. R.J. Greenwald, G.J. Freeman, and A.H. Sharpe The B7 family revisited Annu Rev Immunol 23 2005 515
13. J. Lee, Y. Zhuang, and Q.S. Zheng Contributions of PD-1/PD-L1 pathway to interactions of myeloid DCs with T cells in atherosclerosis J Mol Cell Cardiol 46 2009 169
14. G.J. Freeman, A.J. Long, and T. Honjo Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation J Exp Med 192 2000 1027
15. C. Chen, Q.X. Qu, and X.G. Zhang Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells Immunobiology 212 2007 159
16. J.A. Brown, D.M. Dorfman, and F.R. Ma Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production J Immunol 170 2003 1257
17. R. Schoop, P. Wahl, and R.P. Wuthrich Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells Nephrol Dial Transplant 19 2004 2713
18. W.G. Wang, K. Carper, and W. Li PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection Transplantation 86 2008 836
19. R.H. Schwartz, L. Jackson, and W.E. Paul T lymphocyte-enriched murine peritoneal exudate cells. I. A reliable assay for antigen-induced T lymphocyte proliferation J Immunol 115 1975 1330
20. Y.I. Son, S. Egawa, and T. Kanto A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells J Immunol Methods 262 2002 145
21. I.L. Tourkova, Z.R. Yurkovetsky, and G.V. Shurin Mechanisms of dendritic cell-induced T cell proliferation in the primary MLR assay Immunol Lett 78 2001 75
22. S. Oehen, K. Brduscha-Riem, and B. Odermatt A simple method for evaluating the rejection of grafted spleen cells by flow cytometry and tracing adoptively transferred cells by light microscopy J Immunol Methods 207 1997 33
23. V. Viglietta, and S.J. Khoury Modulating co-stimulation Neurotherapeutics 4 2007 666
24. Z. Zeng, X. Liu, and Y. Tang Biophysical studies on the differentiation of human CD14 monocytes into dendritic cells Cell Biochem Biophys 45 2006 19
25. D.Y. Lin, Y. Tanaka, and D.N. Garboczi The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors Proc Natl Acad Sci USA 105 2008 3011
26. S.K. Subudhi, P. Zhou, and Y.X. Fu Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection J Clin Invest 113 2004 694
27. S.J. Khoury, and M.H. Sayegh The roles of the new negative T cell co-stimulatory pathways in regulating autoimmunity Immunity 20 2004 529
28. S.K. Subudhi, M.L. Alegre, and Y.X. Fu The balance of immune responses: Co-stimulation verse co-inhibition J Mol Med 83 2005 193
29. B.T. Fife, K.E. Pauken, and J.A. Bluestone Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal Nat Immunol 10 2009 1185
30. + regulatory T-Cell activity to suppress alloimmune responses Transplantation 83 2007 774
31. S.E. Sandner, M.R. Clarkson, and M.H. Sayegh Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo J Immunol 174 2005 3408
32. E. Ozkaynak, L.Q. Wang, and W.W. Hancock Programmed death-1 targeting can promote allograft survival J Immunol 169 2002 6546
33. X. Wen, H.F. Zhu, and G.X. Shen Transplantation of NIT-1 cells expressing PD-L1 for treatment of streptozotocin-induced diabetes Transplantation 86 2008 1596
34. P. Fiorina, M. Jurewicz, and R. Abdi Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1 J Immunol 186 2011 121
35. N. Koga, J. Suzuki, and M. Isobe Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts Arterioscler Thromb Vasc Biol 24 2004 2057
36. H. Ji, X. Shen, and J.W. Kupiec-Weglinski Programmed death-1/B7-H1 negative co-stimulation protects mouse liver against ischemia and reperfusion injury Hepatology 52 2010 1380
37. T. Magnus, B. Schreiner, and H. Wiendl Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: Implications for immune responses and autoimmunity in the CNS J Neurosci 25 2005 2537
38. M. Morita, M. Fujino, and X.K. Li PD-1/B7-H1 interaction contribute to the spontaneous acceptance of mouse liver allograft Am J Transplant 10 2010 40
39. + type 1 T regulatory subset through IFN-γ-secreting Th1 cells J Immunol 177 2006 3606
40. X.Y. Cheng, R. Vankayalapati, and Z.H. Dai Interaction of programmed death-1 and programmed death-1 ligand-1 contributes to testicular immune privilege Transplantation 87 2009 1778
41. H. Dai, H.F. Zhu, and M. Fang Programmed death-1 signaling is essential for the skin allograft protection by alternatively activated dendritic cell infusion in mice Transplantation 88 2009 864
42. Y. Jin, S.K. Chauhan, and R. Dana A novel function for programmed death ligand-1 regulation of angiogenesis Am J Pathol 178 2011 1922